(Q36128828)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15896237%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Administration of enoxaparin by continuous infusion in a naturalistic setting: analysis of renal function and safety (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15896237%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15896237%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Feng Y

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15896237%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Bobek MB

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15896237%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Bies RR

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15896237%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Pruchnicki MC

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15896237%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Dasta JF

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15896237%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15896237%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Pharmacy and Therapeutics

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15896237%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15896237%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15896237%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

207-213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15896237%20AND%20SRC:MED&resulttype=core&format=json

Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Thromboprophylaxis in medical patients: focus on France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Treatment of acute pulmonary embolism by a low molecular weight heparin fraction. A preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Pharmacokinetics of a low molecular weight heparin, logiparin, after intravenous and subcutaneous administration to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Population pharmacokinetics and pharmacodynamics of enoxaparin in unstable angina and non-ST-segment elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Correlation of antifactor Xa concentrations with renal function in patients on enoxaparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Enoxaparin and bleeding complications: a review in patients with and without renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Prescribing Patterns and Outcomes of Enoxaparin for Anticoagulation of Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Development of a dosing strategy for enoxaparin in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Enoxaparin in unstable angina patients with renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Delayed elimination of enoxaparine in patients with chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Effect of renal function on the pharmacokinetics of enoxaparin and consequences on dose adjustment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

Anticoagulation in hospitalized patients with renal insufficiency: a comparison of bleeding rates with unfractionated heparin vs enoxaparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00634.X

10.1111/J.1365-2710.2005.00634.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15896237%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference